In this role you will have the overall responsibility for financial planning, budgeting, forecasting and strategic financial analysis, including setting and substantiating targets within the Business Unit MedTech.
Lead and manage budgeting, forecasting, and planning processes in close collaboration with the CFO MedTech and the Executive Leadership Team
Develop and implement FP&A andperformancecontrollingtools, including value stream analyses, to support the corporate strategy
Oversee Cashflow management and reporting for the Business Unit MedTech
Provide active financial support to subsidiaries and collaborate closely with management, controlling, accounting, and operations
Prepare and present management reports, including scenario analyses, sensitivity analyses, and business cases
Drive optimization and digitalization of reporting and planning processes (e.g., SAP Analytics Cloud, Power BI,CoPilote)
Support M&A projects, investment decisions, and risk assessments
Lead, develop, and empower the FP&A team, including talent development and pipeline management
University degree in finance, industrial engineering, BusinessAdministrationor related Field
Minimum 7 years of professional experience in controlling, FP&A, or corporate finance, ideally in an international environment
Proventrack recordin developing and implementing effective FP&A processes and providing insightful financial analysis
Proventrack recordin leading global teams and collaborating with international stakeholders
Very goodknowledge of MS Office and SAP (especially SAP BCS and SAP Analytics Cloud)
Outstanding communication, interculturalcompetenceand leadership skills at executive level
Strong analytical and strategic skills, entrepreneurial thinking, and a solution-oriented mindset
Fluent in English written and spoken,additionallanguages are a plus
Drive the future of MedTech — become part of #futurefresenius and apply now via our online portal!
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
